Literature DB >> 412488

Gold nephropathy: tissue analysis by X-ray fluorescent spectroscopy.

G W Viol, J A Minielly, T Bistricki.   

Abstract

Three patients developed proteinuria following gold therapy for rheumatoid arthritis. The clinical syndrome was a self-limiting proteinuria with normal renal function. By light and electron microscopic appearances the renal lesion was an epimembranous deposit form of membranous glomerulopathy. Immunofluorescent study showed granular deposits of IgG and C3 complement along glomerular basement membranes. By X-ray fluorescent spectroscopic examination, gold was seen to be present within the proximal convoluted tubular cells but was not identified in the glomerular subepithelial deposits. These findings are consistent with an immune-complex form of glomerulopathy in which gold is neither the antigen nor a hapten in the glomerular deposits, and they suggest the hypothesis that antibodies to tubular epithelial antigens induced by gold therapy may be a causative factor in the renal disease associated with gold therapy in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412488

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

1.  The natural course of gold nephropathy: long term study of 21 patients.

Authors:  C L Hall; N J Fothergill; M M Blackwell; P R Harrison; J C MacKenzie; A G MacIver
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-26

Review 2.  Gold colitis induced by auranofin treatment of rheumatoid arthritis: case report and review of the literature.

Authors:  H E Langer; G Hartmann; G Heinemann; K Richter
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

3.  Gold nephropathy in rabbits using an indigenous preparation. A morphological study.

Authors:  A H Nagi; A H Khan
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

4.  beta 2-Microglobulin levels in serum and urine of rheumatoid arthritis patients on gold therapy.

Authors:  D Latt; J B Weiss; M I Jayson
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

5.  Distribution of [3H]-D-penicillamine in mouse kidney. An autoradiographic study.

Authors:  E de Angelis; M L Lombardi; V Ruocco
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

6.  Rheumatoid factor in rheumatoid arthritis associated renal disease and in lupus nephritis.

Authors:  H Helin; M Korpela; J Mustonen; A Pasternack
Journal:  Ann Rheum Dis       Date:  1986-06       Impact factor: 19.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.